At the National Kidney Foundation (NKF) Spring Clinical Meeting, researchers reported an interim analysis of the SPARTAN trial -- a phase II study testing sparsentan (Filspari) as first‑line the ...

In the Philippines, few developments reflect this shift more clearly than the Mall of Asia (MOA) complex in Pasay City. Across a single district, MOA brings together a rare convergence: the sprawling ...

The decrease is largely attributable to lower costs associated with the development of sparsentan as our Phase 3 programs advance towards completion. On a non-GAAP adjusted basis, R&D expenses ...

Travere Therapeutics Inc. reported its first-quarter 2025 earnings, surpassing expectations with an earnings per share (EPS) of -$0.19, compared to the forecasted -$0.55. The company also exceeded ...

The decrease is largely attributable to lower costs associated with the development of sparsentan as our Phase 3 programs advance towards completion. On a non-GAAP adjusted basis, R&D expenses were ...

SHANGHAI, April 30, 2025 /PRNewswire/ -- MUNIK, a leading automotive safety technology firm, has been awarded the world's first ISO/PAS 8800 certification by DEKRA, Germany's largest independent ...

Not long ago, pistol red dots weren’t much more than a novelty or niche competition tool. Today they are the standard. Red dot reflex sights help us shoot pistols faster and more accurately, and we ...

comparator trial in this rare kidney disease. It is a global, randomized, multicenter, double-blind, parallel-arm, active-controlled clinical trial evaluating the safety and efficacy of 400 mg of ...

It is a global, randomized, multicenter, double-blind, parallel-arm, active-controlled clinical trial evaluating the safety and efficacy of 400 mg of sparsentan, compared to 300 mg of irbesartan ...